Note 7 – Accrued expenses
Accrued expenses consisted of the following:
September 30,
June 30,
2026
Personnel and compensation costs
$
20,934
25,862
Consultant
5,000
2,500
Clinical trial costs
693,000
—
Other
9,969
718,934
38,331
The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1
No definition available.